doi:10.1016/j.virs.2025.12.007

[1]
Mingqing Lu, Kunpeng Liu, Yun Peng, Zhe Ding, Yingwen Li, Alexander Tendu, Xue Hu, Ge Gao, Weiwei Guo, Hang Liu, Juhong Rao, Jiaxuan Zhao, Miaoyu Chen, Zhiming Yuan, Gary Wong, Chao Shan, Yanfeng Yao, Jiaming Lan, 2022: Recombinant chimpanzee adenovirus vector vaccine expressing the spike protein provides effective and lasting protection against SARS-CoV-2 infection in mice, Virologica Sinica, 37, 581-590. doi: 10.1016/j.virs.2022.05.006
[2]
Shengxue Luo, Panli Zhang, Peng Zou, Cong Wang, Bochao Liu, Cuiling Wu, Tingting Li, Ling Zhang, Yuming Zhang, Chengyao Li, 2021: A Self-Biomineralized Novel Adenovirus Vectored COVID-19 Vaccine for Boosting Immunization of Mice, Virologica Sinica, 36, 1113-1123. doi: 10.1007/s12250-021-00434-3
[3]
Hewei Zhang, Mingqi Xia, Wei Wang, Decai Ju, Long Cao, Bai Wu, Xin Wang, Ying Wu, Ni Song, Jiaxin Hu, Changxiao Tian, Shucheng Zhang, Hua Wu, 2018: An Attenuated Highly Pathogenic Chinese PRRS Viral Vaccine Confers Cross Protection to Pigs against Challenge with the Emerging PRRSV NADC30-Like Strain, Virologica Sinica, 33, 153-161. doi: 10.1007/s12250-018-0027-0
[4]
Minglong Liang, Zongmei Wang, Chuanjian Wu, Sidong Xiong, Ling Zhao, Chunsheng Dong, 2022: A single dose of recombinant VSV-RABVG vaccine provides full protection against RABV challenge, Virologica Sinica, 37, 455-458. doi: 10.1016/j.virs.2022.02.008
[5]
Dan Shan, Xiaoyan Tang, Renqiang Liu, Dan Pan, Xijun Wang, Jinying Ge, Zhiyuan Wen, Zhigao Bu, 2022: Immunogenicity of a recombinant VSV-Vectored SARS-CoV vaccine induced robust immunity in rhesus monkeys after single-dose immunization, Virologica Sinica, 37, 248-255. doi: 10.1016/j.virs.2022.01.002
[6]
Yihua Jiang, Lingjin Sun, Nan Qiao, Xiang Wang, Caihong Zhu, Man Xing, Hui Liu, Ping Zhou, Dongming Zhou, 2024: A quadrivalent norovirus vaccine based on a chimpanzee adenovirus vector induces potent immunity in mice, Virologica Sinica, 39, 675-684. doi: 10.1016/j.virs.2024.07.002
[7]
汤景元, 姜平*, 蒋文明, 马苏, 李玉峰, 2005: Construction and Immunogenicity of Recombinant Adenovirus Expressing the M protein of Porcine Re- productive and Respiratory Syndrome Virus in Mice, Virologica Sinica, 20, 618-622.
[8]
Ziyang Sheng, Hui Chen, Kaihao Feng, Na Gao, Ran Wang, Peigang Wang, Dongying Fan, Jing An, 2019: Electroporation-Mediated Immunization of a Candidate DNA Vaccine Expressing Dengue Virus Serotype 4 prM-E Antigen Confers Long-Term Protection in Mice, Virologica Sinica, 34, 88-96. doi: 10.1007/s12250-019-00090-8
[9]
Shibo Jiang, Zheng-Li Shi, 2020: The First Disease X is Caused by a Highly Transmissible Acute Respiratory Syndrome Coronavirus, Virologica Sinica, 35, 263-265. doi: 10.1007/s12250-020-00206-5
[10]
Jiaming Lan, Yao Deng, Jingdong Song, Baoying Huang, Wenling Wang, Wenjie Tan, 2018: Significant Spike-Specific IgG and Neutralizing Antibodies in Mice Induced by a Novel Chimeric Virus-Like Particle Vaccine Candidate for Middle East Respiratory Syndrome Coronavirus, Virologica Sinica, 33, 453-455. doi: 10.1007/s12250-018-0064-8
[11]
苏诚钦, 吴亦伦, 陈云华, 何丽娜, 董光锋, 1987: BOVINE ROTAVIRUS ISOLATED FROM AN OUTBREAK OF ACUTE DIARRHEA IN NEWBORN CALVES, Virologica Sinica, 2, 79-.
[12]
Huadong Wang, Yanfeng Yao, Chaoyang Huang, Quanjiao Chen, Jianjun Chen, Ze Chen, 2013: Immunization with Cytomegalovirus Envelope Glycoprotein M and Glycoprotein N DNA Vaccines can Provide Mice with Complete Protection against a Lethal Murine Cytomegalovirus Challenge, Virologica Sinica, 28, 174-182. doi: 10.1007/s12250-013-3330-9
[13]
王宝琴, 张永光, 王小龙, 王永录, 潘丽, 王文秀, 董金杰, 吕建亮, 2005: Protection of Mice Against Challenge with Foot-and-Mouth Disease Virus by Immunization with vp1 Gene Expressed Transgenic N·Benthamiana, Virologica Sinica, 20, 140-144.
[14]
Yang Han, Qingyu Yang, Ying Liu, Ting Shu, Li Yue, Ting Xiao, Qin Zeng, Ying Wu, Xi Zhou, Dingyu Zhang, 2020: Feasibility Study of Mixing Throat Swab Samples for Severe Acute Respiratory Syndrome Coronavirus-2 Screening, Virologica Sinica, 35, 830-832. doi: 10.1007/s12250-020-00254-x
[15]
杜以军, 姜平*, 杨晓玮, 汤景元, 李玉峰, 李永东, 2005: Construction and Indentification of Recombinant Adenovirus Containing Multiple Antigen Epitopes of Swine Foot-and-Mouth Disease Virus, Virologica Sinica, 20, 511-514.
[16]
Yuqian Yan, Shuping Jing, Liqiang Feng, Jing Zhang, Zhiwei Zeng, Min Li, Shan Zhao, Junxian Ou, Wendong Lan, Wenyi Guan, Xiaowei Wu, Jianguo Wu, Donald Seto, Qiwei Zhang, 2021: Construction and Characterization of a Novel Recombinant Attenuated and Replication-Deficient Candidate Human Adenovirus Type 3 Vaccine: "Adenovirus Vaccine Within an Adenovirus Vector", Virologica Sinica, 36, 354-364. doi: 10.1007/s12250-020-00234-1
[17]
李玉峰, 姜平*, 蒋文明, 汤景元, 2006: Construction and Immunogenecity of GP5 Recombinant Adenovirus of Porcine Reproductive and Respira- tory Syndrome virus, Virologica Sinica, 21, 364-367.
[18]
Xinxin Chen, Jifei Yang, Yanhong Ji, Edward Okoth, Bin Liu, Xiaoyang Li, Hong Yin, Qiyun Zhu, 2016: Recombinant Newcastle disease virus expressing African swine fever virus protein 72 is safe and immunogenic in mice, Virologica Sinica, 31, 150-159. doi: 10.1007/s12250-015-3692-2
[19]
王玉燕, 陆承平, 温海, 2005: Canine Coronavirus Detection in Feces from Diarrhea and Health Dogs by Nested-PCR, Virologica Sinica, 20, 41-45.
[20]
Wenling Wang, Baoying Huang, Xiuping Wang, Wenjie Tan, Li Ruan, 2019: Improving Cross-Protection against Influenza Virus Using Recombinant Vaccinia Vaccine Expressing NP and M2 Ectodomain Tandem Repeats, Virologica Sinica, 34, 583-591. doi: 10.1007/s12250-019-00138-9